Summary by Futu AI
DGP Co., Ltd. has completed a significant acquisition of Exicure, Inc. (XCUR) common stock, purchasing 237,223 shares on September 12, 2024. The transaction was carried out directly by DGP Co., Ltd. with a purchase price of $3.00 per share, resulting in a total investment of $711,669. Following this transaction, DGP Co., Ltd. now holds a total of 849,223 shares in Exicure. This move indicates a bolstering of DGP Co., Ltd.'s stake in the biotechnology firm, which specializes in gene regulatory and immunotherapeutic drugs.